Virtual Medicinal Product (VMP)
-
Tarlatamab 10mg powder and solution for solution for infusion vials
Name Details
Current Name
Tarlatamab 10mg powder and solution for solution for infusion vials
|
Start Date
13-02-2025
|
End Date
|
|
Abbreviated Name
Tarlatamab 10mg pdr and soln for inf vials
|
Start Date
13-02-2025
|
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder and solution for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01FX33
SNOMED Codes
Code
|
Start Date
|
End Date
|
44679611000001109 |
13-02-2025 |
|
VMP Ingredients
VMP ingredients table
Tarlatamab |
Based on Ingredient Substance |
|
10 mg |
|
Name
Tarlatamab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Tarlatamab
-
VMP
(Current) Tarlatamab 10mg powder and solution ...
Virtual Medicinal Product Pack (VMPP) Information